IMMUNO STOCKS: In more great emerging Immuno stock $ESLA @ $.90s: Recent $16 one year target by big bio/pharma ETF... PATIENTS UPDATE DUE..Clinical Trial headed by the most prominent Immuno scientist at Memorial Sloan Kettering in Manhattan. The most highly regarded hospital in the USA.
finance.yahoo.com/news/estr...
Website:
estrellabio.com